Port wine stain treatment outcomes have not improved over the past three decades.


Journal

Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 24 11 2018
accepted: 07 03 2019
pubmed: 26 3 2019
medline: 16 1 2020
entrez: 26 3 2019
Statut: ppublish

Résumé

Since the early '80s, the pulsed dye laser has been the standard treatment tool for non-invasive port wine stain (PWS) removal. In the last three decades, a considerable amount of research has been conducted to improve clinical outcomes, given that a fraction of PWS patients proved recalcitrant to laser treatment. Whether this research actually led to increased therapeutic efficacy has not been systematically investigated. To analyse therapeutic efficacy in PWS patients globally from 1986 to date. PubMed was searched for all available PWS trials. Studies with a quartile percentage improvement scale were included, analysed and plotted chronologically. Treatment and patient characteristics were extracted. A mean clearance per study was calculated and plotted. A 5-study simple moving average was co-plotted to portray the trend in mean clearance over time. The data were separately analysed for multiple treatment sessions in previously untreated patients. Sixty-five studies were included (24.3% of eligible studies) comprising 6207 PWS patients. Of all patients, 21% achieved 75-100% clearance. Although a few studies reported remarkably good outcomes in a subset of carefully selected patients, there was no upward trend over time in mean clearance. The efficacy of PWS therapy has not improved in the past decades, despite numerous technical innovations and pharmacological interventions. With an unwavering patient demand for better outcomes, the need for development and implementation of novel therapeutic strategies to clear all PWS is as valid today as it was 30 years ago.

Sections du résumé

BACKGROUND BACKGROUND
Since the early '80s, the pulsed dye laser has been the standard treatment tool for non-invasive port wine stain (PWS) removal. In the last three decades, a considerable amount of research has been conducted to improve clinical outcomes, given that a fraction of PWS patients proved recalcitrant to laser treatment. Whether this research actually led to increased therapeutic efficacy has not been systematically investigated.
OBJECTIVE OBJECTIVE
To analyse therapeutic efficacy in PWS patients globally from 1986 to date.
METHODS METHODS
PubMed was searched for all available PWS trials. Studies with a quartile percentage improvement scale were included, analysed and plotted chronologically. Treatment and patient characteristics were extracted. A mean clearance per study was calculated and plotted. A 5-study simple moving average was co-plotted to portray the trend in mean clearance over time. The data were separately analysed for multiple treatment sessions in previously untreated patients.
RESULTS RESULTS
Sixty-five studies were included (24.3% of eligible studies) comprising 6207 PWS patients. Of all patients, 21% achieved 75-100% clearance. Although a few studies reported remarkably good outcomes in a subset of carefully selected patients, there was no upward trend over time in mean clearance.
CONCLUSION CONCLUSIONS
The efficacy of PWS therapy has not improved in the past decades, despite numerous technical innovations and pharmacological interventions. With an unwavering patient demand for better outcomes, the need for development and implementation of novel therapeutic strategies to clear all PWS is as valid today as it was 30 years ago.

Identifiants

pubmed: 30908756
doi: 10.1111/jdv.15599
pmc: PMC6618082
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1369-1377

Subventions

Organisme : Academic Medical Center SKE Fund
ID : 20090812
Organisme : Stichting Technologische Wetenschap
ID : 12064

Informations de copyright

© 2019 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.

Références

Br J Dermatol. 2003 Oct;149(4):770-5
pubmed: 14616368
J Am Acad Dermatol. 2012 Aug;67(2):289-304
pubmed: 22305042
Lasers Surg Med. 2004;34(2):164-7
pubmed: 15004829
J Am Acad Dermatol. 2012 Nov;67(5):985-90
pubmed: 22342327
Photodiagnosis Photodyn Ther. 2014 Dec;11(4):491-7
pubmed: 24973576
Lasers Surg Med. 2007 Aug;39(7):563-8
pubmed: 17868100
N Engl J Med. 2013 May 23;368(21):1971-9
pubmed: 23656586
J Cosmet Laser Ther. 2014 Dec;16(6):279-83
pubmed: 25060356
J Dermatol. 2011 Dec;38(12):1146-52
pubmed: 22032688
Arch Facial Plast Surg. 2005 Sep-Oct;7(5):287-94
pubmed: 16172335
Arch Pediatr Adolesc Med. 1995 Oct;149(10):1142-4
pubmed: 7550819
Br J Dermatol. 2001 Apr;144(4):814-7
pubmed: 11298542
Hautarzt. 2001 Nov;52(11):1011-5
pubmed: 11757454
Dermatol Surg. 2007 May;33(5):560-6
pubmed: 17451578
PLoS One. 2020 Jul 2;15(7):e0235657
pubmed: 32614899
Br J Plast Surg. 2005 Oct;58(7):968-80
pubmed: 16043156
Australas J Dermatol. 1997 Feb;38(1):15-21
pubmed: 9046647
Dermatol Surg. 2009 Jun;35(6):914-8; discussion 918-9
pubmed: 19397657
Dermatol Surg. 2002 Apr;28(4):309-13
pubmed: 11966787
Dermatology. 1998;197(2):158-61
pubmed: 9732166
Lasers Surg Med. 2017 Jan;49(1):97-103
pubmed: 27121176
J Am Acad Dermatol. 2000 Apr;42(4):667-71
pubmed: 10727315
Dermatol Surg. 2006 Jan;32(1):41-8
pubmed: 16393597
Lasers Surg Med. 2016 Nov;48(9):852-858
pubmed: 27669109
Clin Exp Dermatol. 2003 Sep;28(5):556-7
pubmed: 12950354
J Cosmet Laser Ther. 2003 Apr;5(1):7-13
pubmed: 12745594
J Invest Dermatol. 1995 May;104(5):798-802
pubmed: 7738359
J Cosmet Laser Ther. 2018 Apr;20(2):77-84
pubmed: 29384394
J Dermatol Sci. 2011 Sep;63(3):139-47
pubmed: 21664109
Science. 1983 Apr 29;220(4596):524-7
pubmed: 6836297
Lasers Med Sci. 2018 Nov;33(8):1707-1715
pubmed: 29744754
Wiad Lek. 2005;58(7-8):391-6
pubmed: 16425790
J Drugs Dermatol. 2013 Jan;12(1):66-71
pubmed: 23377330
J Cosmet Laser Ther. 2013 Apr;15(2):85-90
pubmed: 23464706
J Cosmet Laser Ther. 2009 Mar;11(1):11-3
pubmed: 18830868
Thromb Haemost. 2005 Feb;93(2):242-56
pubmed: 15711739
Br J Dermatol. 2002 Mar;146(3):440-7
pubmed: 11952544
Arch Dermatol. 1988 Jun;124(6):889-96
pubmed: 3377518
N Engl J Med. 2007 Mar 22;356(12):1235-40
pubmed: 17377161
J Cosmet Laser Ther. 2010 Feb;12(1):2-6
pubmed: 20085450
Acta Derm Venereol. 2003;83(3):210-3
pubmed: 12816158
J Drugs Dermatol. 2015 Nov;14(11):1336-40
pubmed: 26580884
Medicine (Baltimore). 2015 Oct;94(40):e1717
pubmed: 26448027
Dermatol Surg. 2000 Jul;26(7):657-61
pubmed: 10886274
Actas Dermosifiliogr. 2016 Sep;107(7):591-6
pubmed: 27436799
Dermatol Surg. 1999 Oct;25(10):767-72
pubmed: 10594577
Dermatol Surg. 2007 Aug;33(8):951-6
pubmed: 17661938
J Cosmet Dermatol. 2008 Jun;7(2):127-31
pubmed: 18482016
Dermatol Surg. 2004 Feb;30(2 Pt 1):158-62; discussion 162
pubmed: 14756643
Dermatol Surg. 2004 Jun;30(6):887-90; discussion 890-1
pubmed: 15171767
J Am Acad Dermatol. 2017 Apr;76(4):695-702
pubmed: 27955934
Lasers Med Sci. 2002;17(2):70-8
pubmed: 12111589
J Am Acad Dermatol. 2006 Mar;54(3):487-93
pubmed: 16488301
J Am Acad Dermatol. 1991 Mar;24(3):467-72
pubmed: 2061448
J Eur Acad Dermatol Venereol. 2007 Oct;21(9):1229-33
pubmed: 17894710
Lasers Surg Med. 2003;33(5):282-7
pubmed: 14677155
Clin Exp Dermatol. 2009 Oct;34(7):e436-7
pubmed: 19747305
Dermatol Surg. 2016 Jun;42(6):717-26
pubmed: 27158882
Ann Biomed Eng. 2012 Feb;40(2):486-506
pubmed: 22016324
J Am Acad Dermatol. 2016 Feb;74(2):380-3
pubmed: 26775782
J Cosmet Laser Ther. 2010 Aug;12(4):183-7
pubmed: 20635848
Lasers Surg Med. 2002;31(5):352-8
pubmed: 12430153
Dermatol Surg. 2009 Dec;35(12):1933-41
pubmed: 19889008
G Ital Dermatol Venereol. 2016 Jun;151(3):281-6
pubmed: 27176079
Singapore Med J. 2000 Jan;41(1):24-8
pubmed: 10783676
Dermatol Surg. 2005 May;31(5):509-17
pubmed: 15962732
Lasers Surg Med. 2002;30(1):44-7
pubmed: 11857603
Lasers Surg Med. 2013 Apr;45(4):216-24
pubmed: 23619901
Lasers Med Sci. 2015 Apr;30(3):1041-6
pubmed: 25487186
J Cosmet Laser Ther. 2010 Apr;12(2):54-60
pubmed: 20331340
Br J Dermatol. 2017 Dec;177(6):1601-1611
pubmed: 28599054
Br J Dermatol. 2006 Apr;154(4):676-9
pubmed: 16536811
Clin Exp Dermatol. 1996 Mar;21(2):88-92
pubmed: 8759191
Drug Des Devel Ther. 2014 Dec 12;8:2531-8
pubmed: 25548515
J Cosmet Laser Ther. 2014 Jan;16(1):21-5
pubmed: 24215420
J Cosmet Laser Ther. 2017 Nov;19(7):418-421
pubmed: 28657379
J Am Acad Dermatol. 1990 Dec;23(6 Pt 1):1142-8
pubmed: 2273116
Ann Dermatol. 2012 Aug;24(3):306-10
pubmed: 22879714
Dermatol Surg. 2001 Jul;27(7):633-6
pubmed: 11442613
Lasers Surg Med. 2004;34(2):168-73
pubmed: 15004830

Auteurs

M I van Raath (MI)

Department of Pharmaceutics, College of Medicine, Jiaxing University, Jiaxing, China.
Department of Experimental Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

S Chohan (S)

Department of Experimental Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

A Wolkerstorfer (A)

Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

C M A M van der Horst (CMAM)

Department of Plastic, Reconstructive, and Hand Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

G Storm (G)

Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, the Netherlands.

M Heger (M)

Department of Pharmaceutics, College of Medicine, Jiaxing University, Jiaxing, China.
Department of Experimental Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH